UBS Group’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,084
| Closed | -$87.7K | – | 10480 |
|
|
2024
Q1 | $87.7K | Buy |
4,084
+4,042
| +9,624% | +$26.8K | ﹤0.01% | 6282 |
|
|
2023
Q4 | $154 | Buy |
42
+5
| +14% | +$20 | ﹤0.01% | 8861 |
|
|
2023
Q3 | $144 | Hold |
37
| – | – | ﹤0.01% | 8797 |
|
|
2023
Q2 | $156 | Sell |
37
-591
| -94% | -$1.87K | ﹤0.01% | 8440 |
|
|
2023
Q1 | $1.87K | Buy |
628
+590
| +1,553% | +$2.18K | ﹤0.01% | 8630 |
|
|
2022
Q4 | $188 | Buy |
+38
| New | +$145 | ﹤0.01% | 10327 |
|
|
2022
Q3 | – | Sell |
-124
| Closed | -$1K | – | 11408 |
|
|
2022
Q2 | $1K | Buy |
+124
| New | +$1.13K | ﹤0.01% | 10112 |
|
|
2022
Q1 | – | Sell |
-381
| Closed | -$18K | – | 11278 |
|
|
2021
Q4 | $18K | Buy |
+381
| New | +$40K | ﹤0.01% | 8023 |
|
|
2021
Q2 | – | Sell |
-183
| Closed | -$18K | – | 10043 |
|
|
2021
Q1 | $18K | Buy |
+183
| New | +$23.9K | ﹤0.01% | 7489 |
|
UBS Group's LABP Position: Q2 2024 in Review
UBS Group sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2024, closing a stake of 4,084 shares — an estimated $87.7K sold.
UBS Group first reported a position in LABP in Q1 2021 and held it in 9 quarters. The position peaked at $87.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold LABP as of Q2 2024.
- UBS Group reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- UBS Group sold 4,084 Landos Biopharma, Inc. Common Stock shares in Q2 2024, an estimated $87.7K.
- UBS Group first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
- UBS Group's Landos Biopharma, Inc. Common Stock position peaked at $87.7K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2024.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.